Roles of Acyl-CoA: Diacylglycerol acyltransferases 1 and 2 in triacylglycerol synthesis and secretion in primary hepatocytes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 5, 2015, Pages 1080-1091

  Li, Chen ^a   Li, Lena ^a,b   Lian, Jihong ^a,b   Watts, Russell ^a,b   Nelson, Randal ^a,b   Goodwin, Bryan ^c   Lehner, Richard ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

diacylglycerol o acyltransferase; hepatocytes; triglycerides

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 2; FAT DROPLET; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN; ACYL COENZYME A; DGAT1 PROTEIN, MOUSE; DGAT2 PROTEIN, MOUSE; DIACYLGLYCEROL ACYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENDOPLASMIC RETICULUM; ENZYME INACTIVATION; ENZYME INHIBITION; ESTERIFICATION; FATTY ACID OXIDATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN SECRETION; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; ROLE PLAYING; SECRETION (PROCESS); SENSITIVITY AND SPECIFICITY;

ACYL COENZYME A; ANIMALS; CELLS, CULTURED; DIACYLGLYCEROL O-ACYLTRANSFERASE; HEPATOCYTES; HUMANS; LIPID METABOLISM; LIPOGENESIS; MICE; ROLE; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 84933035623     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304584     Document Type: Article

References (58)

1. Browning JD, Horton JD, Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004 114 147 152. doi: 10.1172/JCI22422
2. Fabbrini E, Sullivan S, Klein S, Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010 51 679 689. doi: 10.1002/hep.23280
3. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV Jr., Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 2008 49 2283 2301. doi: 10.1194/jlr.R800018-JLR200
4. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RV Jr., Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 2000 25 87 90. doi: 10.1038/75651
5. Stone SJ, Myers HM, Watkins SM, Brown BE, Feingold KR, Elias PM, Farese RV Jr., Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 2004 279 11767 11776. doi: 10.1074/jbc.M311000200
6. Choi CS, Savage DB, Kulkarni A, Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J Biol Chem 2007 282 22678 22688. doi: 10.1074/jbc.M704213200
7. Yu XX, Murray SF, Pandey SK, Booten SL, Bao D, Song XZ, Kelly S, Chen S, McKay R, Monia BP, Bhanot S, Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 2005 42 362 371. doi: 10.1002/hep.20783
8. Buhman KK, Smith SJ, Stone SJ, Repa JJ, Wong JS, Knapp FF Jr, Burri BJ, Hamilton RL, Abumrad NA, Farese RV Jr., DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J Biol Chem 2002 277 25474 25479. doi: 10.1074/jbc.M202013200
9. Cao J, Zhou Y, Peng H, Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases. J Biol Chem 2011 286 41838 41851. doi: 10.1074/jbc.M111.245456
10. Chen HC, Farese RV Jr., Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice. Arterioscler Thromb Vasc Biol 2005 25 482 486. doi: 10.1161/01.ATV.0000151874.81059.ad
11. Yang LY, Kuksis A, Myher JJ, Steiner G, Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies. J Lipid Res 1995 36 125 136
12. Lankester DL, Brown AM, Zammit VA, Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty acid for the synthesis of triacylglycerol secreted by cultured rat hepatocytes. J Lipid Res 1998 39 1889 1895
13. Lehner R, Lian J, Quiroga AD, Lumenal lipid metabolism: implications for lipoprotein assembly. Arterioscler Thromb Vasc Biol 2012 32 1087 1093. doi: 10.1161/ATVBAHA.111.241497
14. Wiggins D, Gibbons GF, The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas. Biochem J 1992 284 Pt 2 457 462
15. Gibbons GF, Wiggins D, Intracellular triacylglycerol lipase: its role in the assembly of hepatic very-low-density lipoprotein (VLDL). Adv Enzyme Regul 1995 35 179 198
16. Lian J, Wei E, Wang SP, Quiroga AD, Li L, Di Pardo A, van der Veen J, Sipione S, Mitchell GA, Lehner R, Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice. Hepatology 2012 56 2154 2162. doi: 10.1002/hep.25881
17. Nourbakhsh M, Douglas DN, Pu CH, Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production. J Hepatol 2013 59 336 343. doi: 10.1016/j.jhep.2013.03.022
18. Wei E, Ben Ali Y, Lyon J, Wang H, Nelson R, Dolinsky VW, Dyck JR, Mitchell G, Korbutt GS, Lehner R, Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metab 2010 11 183 193. doi: 10.1016/j.cmet.2010.02.005
19. Abo-Hashema KA, Cake MH, Power GW, Clarke D, Evidence for triacylglycerol synthesis in the lumen of microsomes via a lipolysis-esterification pathway involving carnitine acyltransferases. J Biol Chem 1999 274 35577 35582
20. Stone SJ, Levin MC, Farese RV Jr., Membrane topology and identification of key functional amino acid residues of murine acyl-CoA:diacylglycerol acyltransferase-2. J Biol Chem 2006 281 40273 40282. doi: 10.1074/jbc.M607986200
21. Waterman IJ, Price NT, Zammit VA, Distinct ontogenic patterns of overt and latent DGAT activities of rat liver microsomes. J Lipid Res 2002 43 1555 1562
22. Owen M, Zammit VA, Evidence for overt and latent forms of DGAT in rat liver microsomes. Implications for the pathways of triacylglycerol incorporation into VLDL. Biochem Soc Trans 1997 25 21S
23. Owen MR, Corstorphine CC, Zammit VA, Overt and latent activities of diacylglycerol acytransferase in rat liver microsomes: possible roles in very-low-density lipoprotein triacylglycerol secretion. Biochem J 1997 323 Pt 1 17 21
24. McFie PJ, Stone SL, Banman SL, Stone SJ, Topological orientation of acyl-CoA:diacylglycerol acyltransferase-1 (DGAT1) and identification of a putative active site histidine and the role of the n terminus in dimer/tetramer formation. J Biol Chem 2010 285 37377 37387. doi: 10.1074/jbc.M110.163691
25. Wurie HR, Buckett L, Zammit VA, Evidence that diacylglycerol acyltransferase 1 (DGAT1) has dual membrane topology in the endoplasmic reticulum of HepG2 cells. J Biol Chem 2011 286 36238 36247. doi: 10.1074/jbc.M111.251900
26. Wilfling F, Wang H, Haas JT, Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. Dev Cell 2013 24 384 399. doi: 10.1016/j.devcel.2013.01.013
27. Xu N, Zhang SO, Cole RA, McKinney SA, Guo F, Haas JT, Bobba S, Farese RV Jr, Mak HY, The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface. J Cell Biol 2012 198 895 911. doi: 10.1083/jcb.201201139
28. Wang H, Gilham D, Lehner R, Proteomic and lipid characterization of apolipoprotein B-free luminal lipid droplets from mouse liver microsomes: implications for very low density lipoprotein assembly. J Biol Chem 2007 282 33218 33226. doi: 10.1074/jbc.M706841200
29. AHN K, Boehm M, Cabral S, Diacylglycerol acyltransferase 2 inhibitors. Google Patents; 2013
30. Dow RL, Li JC, Pence MP, Discovery of PF-04620110, a potent, selective, and orally bioavailable inhibitor of DGAT-1. ACS Med Chem Lett 2011 2 407 412. doi: 10.1021/ml200051p
31. Qi J, Lang W, Geisler JG, The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and-2. J Lipid Res 2012 53 1106 1116. doi: 10.1194/jlr.M020156
32. Stals HK, Top W, Declercq PE, Regulation of triacylglycerol synthesis in permeabilized rat hepatocytes. Role of fatty acid concentration and diacylglycerol acyltransferase. FEBS Lett 1994 343 99 102
33. Bagnato C, Igal RA, Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-Transformed human lung fibroblasts. J Biol Chem 2003 278 52203 52211. doi: 10.1074/jbc.M305760200
34. Cornell R, Vance DE, Binding of CTP: phosphocholine cytidylyltransferase to large unilamellar vesicles. Biochim Biophys Acta 1987 919 37 48
35. Jacobs RL, Zhao Y, Koonen DP, Sletten T, Su B, Lingrell S, Cao G, Peake DA, Kuo MS, Proctor SD, Kennedy BP, Dyck JR, Vance DE, Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity. J Biol Chem 2010 285 22403 22413. doi: 10.1074/jbc.M110.108514
36. Krahmer N, Guo Y, Wilfling F, Hilger M, Lingrell S, Heger K, Newman HW, Schmidt-Supprian M, Vance DE, Mann M, Farese RV Jr, Walther TC, Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase. Cell Metab 2011 14 504 515. doi: 10.1016/j.cmet.2011.07.013
37. Higashi Y, Itabe H, Fukase H, Mori M, Fujimoto Y, Takano T, Transmembrane lipid transfer is crucial for providing neutral lipids during very low density lipoprotein assembly in endoplasmic reticulum. J Biol Chem 2003 278 21450 21458. doi: 10.1074/jbc.M301376200
38. Ong KT, Mashek MT, Bu SY, Greenberg AS, Mashek DG, Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology 2011 53 116 126. doi: 10.1002/hep.24006
39. Wu JW, Wang SP, Alvarez F, Casavant S, Gauthier N, Abed L, Soni KG, Yang G, Mitchell GA, Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology 2011 54 122 132. doi: 10.1002/hep.24338
40. Chen Z, Norris JY, Finck BN, Peroxisome proliferator-Activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB). J Biol Chem 2010 285 25996 26004. doi: 10.1074/jbc.M110.141598
41. Li X, Ye J, Zhou L, Gu W, Fisher EA, Li P, Opposing roles of cell death-inducing DFF45-like effector B and perilipin 2 in controlling hepatic VLDL lipidation. J Lipid Res 2012 53 1877 1889. doi: 10.1194/jlr.M026591
42. Magnusson B, Asp L, Boström P, Ruiz M, Stillemark-Billton P, Lindén D, Borén J, Olofsson SO, Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins. Arterioscler Thromb Vasc Biol 2006 26 1566 1571. doi: 10.1161/01.ATV.0000223345.11820.da
43. Ye J, Li JZ, Liu Y, Li X, Yang T, Ma X, Li Q, Yao Z, Li P, Cideb, an ER-And lipid droplet-Associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab 2009 9 177 190. doi: 10.1016/j.cmet.2008.12.013
44. Kim E, Young SG, Genetically modified mice for the study of apolipoprotein B. J Lipid Res 1998 39 703 723
45. Spring DJ, Chen-Liu LW, Chatterton JE, Elovson J, Schumaker VN, Lipoprotein assembly. Apolipoprotein B size determines lipoprotein core circumference. J Biol Chem 1992 267 14839 14845
46. Yamazaki T, Sasaki E, Kakinuma C, Yano T, Miura S, Ezaki O, Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. J Biol Chem 2005 280 21506 21514. doi: 10.1074/jbc.M412989200
47. Liang JJ, Oelkers P, Guo C, Chu PC, Dixon JL, Ginsberg HN, Sturley SL, Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells. J Biol Chem 2004 279 44938 44944. doi: 10.1074/jbc.M408507200
48. Millar JS, Stone SJ, Tietge UJ, Tow B, Billheimer JT, Wong JS, Hamilton RL, Farese RV Jr, Rader DJ, Short-Term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production. J Lipid Res 2006 47 2297 2305. doi: 10.1194/jlr.M600213-JLR200
49. Wurie HR, Buckett L, Zammit VA, Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells. FEBS J 2012 279 3033 3047. doi: 10.1111/j.1742-4658.2012.08684.x
50. Gibbons GF, Khurana R, Odwell A, Seelaender MC, Lipid balance in HepG2 cells: active synthesis and impaired mobilization. J Lipid Res 1994 35 1801 1808
51. Lehner R, Vance DE, Cloning and expression of a cDNA encoding a hepatic microsomal lipase that mobilizes stored triacylglycerol. Biochem J 1999 343 Pt 1 1 10
52. Wu X, Shang A, Jiang H, Ginsberg HN, Low rates of apoB secretion from HepG2 cells result from reduced delivery of newly synthesized triglyceride to a "secretion-coupled" pool. J Lipid Res 1996 37 1198 1206
53. Man WC, Miyazaki M, Chu K, Ntambi J, Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis. J Lipid Res 2006 47 1928 1939. doi: 10.1194/jlr.M600172-JLR200
54. Shimomura I, Bashmakov Y, Horton JD, Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999 274 30028 30032
55. Brookheart RT, Michel CI, Schaffer JE, As a matter of fat. Cell Metab 2009 10 9 12. doi: 10.1016/j.cmet.2009.03.011
56. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Schaffer JE, Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 2003 100 3077 3082. doi: 10.1073/pnas.0630588100
57. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H, High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000 49 1939 1945
58. Ganji SH, Tavintharan S, Zhu D, Xing Y, Kamanna VS, Kashyap ML, Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells. J Lipid Res 2004 45 1835 1845. doi: 10.1194/jlr.M300403-JLR200